Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
1841 |
|
| Actual shortage: | 45 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 13 (1%) | |
| Resolved: | 1782 (97%) | |
Discontinuation Reports |
82 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 79 (96%) | |
| Reversed: | 2 (2%) | |
Late reports |
439 (23%) |
|
Overdue reports |
1 (2%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FLUCONAZOLE INJECTION SDZ | 2MG | SOLUTION | Resolved | 2023-01-27 | 2023-03-14 | 182556 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 2MG | SOLUTION | Resolved | 2023-01-27 | 2023-03-06 | 182563 |
| SANDOZ RISPERIDONE | 2MG | TABLET | Resolved | 2023-01-27 | 2023-03-07 | 182578 |
| FLUCONAZOLE INJECTION SDZ | 2MG | SOLUTION | Resolved | 2023-03-20 | 2023-04-18 | 187430 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 2MG | SOLUTION | Resolved | 2023-03-20 | 2023-04-13 | 187433 |
| SANDOZ GLIMEPIRIDE | 2MG | TABLET | Resolved | 2023-04-04 | 2023-05-09 | 188654 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 2MG | SOLUTION | Resolved | 2023-04-21 | 2023-05-09 | 190148 |
| SANDOZ RISPERIDONE | 2MG | TABLET | Resolved | 2023-05-30 | 2023-06-20 | 193391 |
| ONDANSETRON INJECTION USP -(PRESERVATIVE FREE) | 2MG | SOLUTION | Resolved | 2023-08-21 | 2024-01-03 | 202547 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 2MG | SOLUTION | Resolved | 2023-08-29 | 2023-08-30 | 203181 |
| SANDOZ ENALAPRIL | 2MG | TABLET | Resolved | 2023-09-05 | 2023-10-31 | 203659 |
| SANDOZ GLIMEPIRIDE | 2MG | TABLET | Resolved | 2023-10-30 | 2023-11-28 | 208541 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 2MG | SOLUTION | Resolved | 2024-01-08 | 2024-02-01 | 215339 |
| SANDOZ TRANDOLAPRIL | 2MG | CAPSULE | Resolved | 2024-04-02 | 2024-05-28 | 224183 |
| SANDOZ ENALAPRIL | 2MG | TABLET | Actual shortage | 2024-04-16 | 2024-04-16 | 225215 |
| SANDOZ RISPERIDONE | 3.0MG | TABLET | Resolved | 2021-02-08 | 2021-09-28 | 133526 |
| SANDOZ RISPERIDONE | 3.0MG | TABLET | Resolved | 2021-09-28 | 2021-10-16 | 146330 |
| SANDOZ RISPERIDONE | 3.0MG | TABLET | Resolved | 2022-12-12 | 2022-12-28 | 177938 |
| SANDOZ AMPHETAMINE XR | 3.75MG 3.75MG 3.75MG 3.75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-05-08 | 2017-09-07 | 9451 |
| SANDOZ AMPHETAMINE XR | 3.75MG 3.75MG 3.75MG 3.75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-02-04 | 2019-06-28 | 74599 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ-DICLOFENAC SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-08-18 | 2021-08-18 | 144303 |
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |